| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |